Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.89 USD | -8.70% |
|
-19.57% | -37.21% |
Jul. 01 | Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000 Growth Index | CI |
Jul. 01 | Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell Small Cap Comp Growth Index | CI |
Business Summary
Number of employees: 94
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Programmable Epigenomic mRNA Medicines
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +49.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +49.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Barbara Y. Chan
DFI | Director of Finance/CFO | 60 | - |
Samir Padalkar
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Ling Zeng
ADM | Chief Administrative Officer | 55 | 22-03-29 |
Thomas McCauley
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Mendlein
BRD | Director/Board Member | 64 | 19-12-31 |
Christian Schade
CHM | Chairman | 63 | 23-07-09 |
Mary Szela
BRD | Director/Board Member | 60 | 19-05-31 |
Richard Young
BRD | Director/Board Member | 70 | 17-07-31 |
Michelle Werner
BRD | Director/Board Member | 48 | 23-08-27 |
Elliott Levy
BRD | Director/Board Member | 65 | 21-02-28 |
Rainer Boehm
BRD | Director/Board Member | 63 | 22-08-31 |
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,154,985 | 50,748,363 ( 92.01 %) | 0 | 92.01 % |
Company contact information
![address Omega Therapeutics, Inc.(OMGA)](https://cdn.zonebourse.com/static/address/125290480.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.21% | 104M | |
+16.59% | 44.44B | |
-10.62% | 37.68B | |
+41.82% | 39.84B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- OMGA Stock
- Company Omega Therapeutics, Inc.